| 注册
首页|期刊导航|中国循证儿科杂志|地西泮预防热性惊厥复发的疗效与安全性的系统评价和Meta分析

地西泮预防热性惊厥复发的疗效与安全性的系统评价和Meta分析

李少军 谭利平 许峰 郭鹏飞 邹庆 何富香 周璟

中国循证儿科杂志Issue(6):429-435,7.
中国循证儿科杂志Issue(6):429-435,7.DOI:10.3969/j.issn.1673-5501.2014.06.006

地西泮预防热性惊厥复发的疗效与安全性的系统评价和Meta分析

Efficacy and safety of prophylactic diazepam on the prevention of febrile seizure in children:a systematic review and meta-analysis

李少军 1谭利平 1许峰 1郭鹏飞 1邹庆 1何富香 1周璟1

作者信息

  • 1. 重庆医科大学附属儿童医院急诊科,儿童发育疾病研究教育部重点实验室,重庆市儿童发育重大疾病诊治与预防国际科技合作基地,儿科学重庆市重点实验室 重庆,410014
  • 折叠

摘要

Abstract

Objective To systematically review the efficacy and safety of intermittent use of diazepam to prevent recurrence of febrile seizure(FS)using meta-analysis methods. Methods The Cochrane Library(Issue 7,2014),PubMed,EMBASE,CBM, CNKI,VIP and Wanfang Data were searched for the randomized controlled trails( RCTs)about prophylactic use of dizapam to control FS relapse in children up to July 2014. Two reviewers independently screened literature according to the inclusion and exclusion criteria,extracted data and evaluated the methodological quality of included studies. Then meta-analysis was performed using RevMan 5. 2 software,in subjects with low-,moderate- and high-risk of FS recurrence respectively. Results Nine studies involving 1 578 patients were included. The methodological quality evaluation defined generation of random sequences for randomization,allocation concealment,and blinding as high bias risk;selective result reporting,loss of follow up,and alternative sources of bias as low bias risk. Meta-analysis showed no significant difference in FS recurrence rate in 6-month treatment group and intermittent diazepam compared with the control group(RR=0. 62,95% CI:0. 34 to 1. 13,P=0. 12;RD= _0. 07,95%CI:_0. 16 to 0. 02). However,FS relapse rate was markedly decreased at 12 months treatment(RR=0. 59,95%CI:0. 38~0. 91, P=0. 02;RD= _0. 12,95%CI:_0. 22~ _0. 02)and 24 months treatment(RR=0. 54,95%CI:0. 37 to 0. 78,P=0. 001;RD= _0. 17,95%CI:_0. 27 to _0. 07),compared with the control group. The results of subgroup analysis by FS recurrence risk factors indicated that reduced FS recurrence rate was found in the moderate-risk group(6 months:RR=0. 31,95%CI:0. 15 to 0. 62,P=0. 000 9;12 months:RR=0. 39,95%CI:0. 20 to 0. 75 ,P=0. 005;24 months:RR=0. 43,95%CI:0. 24 to 0. 77,P=0. 005)and high-risk group(6 months:RR=0. 24,95%CI:0. 10 to 0. 15;12 months:RR=0. 27,P=0. 00 09. 95%CI:0. 13 to 0. 58,P=0. 000 7;24 months:RR=0. 35,95%CI:0. 19 to 0. 62,P=0. 000 4)but not in the low-risk group (6 months:RR=0. 69,95%CI:0. 40 to 1. 21,P=0. 20;12 months:RR=0. 81,95%CI:0. 47 to 1. 42,P=0. 46;24 months:RR=0. 71,95%CI:0. 45 to 1. 11,P=0. 14). No serious complications about diazepam was reported in the included studies. Conclusion Intermittent diazepam for 12 months or 24 months can effectively reduce FS recurrence rate,and shows good efficacy for moderate-risk and high-risk patients. Additional high quality studies are still expected to verify the above conclusion.

关键词

热性惊厥/地西泮/抗惊厥药物/儿童/Meta分析/随机对照试验

Key words

Febrile seizure/Diazepam/Anticonvulsant drug/Chlidren/Meta-analysis/Randomized controlled trial

引用本文复制引用

李少军,谭利平,许峰,郭鹏飞,邹庆,何富香,周璟..地西泮预防热性惊厥复发的疗效与安全性的系统评价和Meta分析[J].中国循证儿科杂志,2014,(6):429-435,7.

中国循证儿科杂志

OA北大核心CSCDCSTPCD

1673-5501

访问量0
|
下载量0
段落导航相关论文